The Association for Accessible Medicines has joined the Coalition Against Patent Abuse, a new stakeholder association that is focused on fighting abuses of the patent system.
Adacel is now the first and only Tdap vaccine in the United States approved for a repeat dose in people between the ages of 10-to-64 years old, administered eight or more years after the first vaccination.